A Clinical Study to Evaluate the Efficacy, Tolerability, and Safety of Bempedoic Acid
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 245 participants.
Also called NCT06780410
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 245 participants
- Sponsor
- Registry
-
NCT06780410
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT06780410. Randomized; double masking; primary purpose treatment. Start 2024-12-20 (actual); primary completion 2025-08-05 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Clinical Study to Evaluate the Efficacy, Tolerability, and Safety of Bempedoic Acid
- Condition
- Primary Hyperlipidemia
- Intervention (Drug)
- Bempedoic Acid Tablet
- Intervention (Drug)
- Placebo
- Lead sponsor
- Gan & Lee Pharmaceuticals.
Record details
- Record id
cardio:ct-nct06780410- Content hash
74b77e7905bf8ed24a0b0f9bc7766a6c057650dbf4ba40a7b93316cccb9be62a